Theragenics profit rises 6% - Atlanta Business Chronicle:

pabigy.wordpress.com
The Atlanta-based surgical products and cancer treatmentscompanyu (NYSE: TGX) posted net income of $1.8 millionm on $16 million in revenue, compared with net incomew of $1.7 million on $14.4 million in revenue in the third quarter of 2006. Third-quarter earnings were flat at 5 cent sa share. The results for the third quarter of 2006 includrea $1 million income tax benefit, whichh significantly reduced the effective incomd tax rate and increased earnings per share by 3 cents. The thirdc quarter of 2007 has been reporteed at a fully taxed normal The results for 2006 also includeda $400,000o one-time license fee of $400,000.
"Ourd diversification strategy continues to deliver strong resulta as we posted another quarter ofrecorrd revenue," said M. Christin e Jacobs, chairman a CEO. "Nearlty half of third quarter revenues was generated by our surgicalproducts business, and both our brachytherapy and surgical products businessees contributed to profitability. Our surgical products businessx has demonstrated its abilityuto grow.
"